Detalhe da pesquisa
1.
Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Nat Methods
; 15(4): 236-237, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29600989
2.
Matrilin-1 is an inhibitor of neovascularization.
J Biol Chem
; 289(20): 14301-9, 2014 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24692560
3.
The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor.
J Biol Chem
; 285(53): 41886-95, 2010 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940305
4.
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.
Nat Commun
; 12(1): 3908, 2021 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162850
5.
SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.
PLoS One
; 15(4): e0231716, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298334
6.
Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T Cells.
CRISPR J
; 3(3): 177-187, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584143
7.
A novel approach to using matrix metalloproteinases for bladder cancer.
J Urol
; 182(5): 2188-94, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19758628
8.
Establishment and biochemical characterization of primary cells of the upper aerodigestive tract.
Clin Hemorheol Microcirc
; 36(1): 47-64, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17211061
9.
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Clin Cancer Res
; 11(15): 5390-5, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061852
10.
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.
Nat Commun
; 12(1): 4500, 2021 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282150
11.
Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence.
Res Rep Urol
; 4: 49-56, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199181
12.
A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.
Mayo Clin Proc
; 87(9): 835-42, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22883743
13.
Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing.
Res Rep Urol
; 4: 33-40, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199178
14.
Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis.
Res Rep Urol
; 4: 65-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199183
15.
A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients.
Res Rep Urol
; 4: 17-26, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199176
16.
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor.
Proc Natl Acad Sci U S A
; 104(24): 10010-5, 2007 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17548836
17.
Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4.
Biochem Biophys Res Commun
; 345(1): 523-9, 2006 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-16682001
18.
A role for antiangiogenic therapy in breast cancer.
Curr Oncol Rep
; 6(1): 42-8, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14664760
19.
Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.
J Biol Chem
; 278(42): 40989-95, 2003 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-12900406